Tyr849

Javascript is not enabled on this browser. This site will not work properly without Javascript.

Home > Phosphorylation Site Page: > Tyr849 - ALK (human)

Site Information
AGGGGRAyGAKTDTF SwissProt Entrez-Gene
Blast this site against: NCBI SwissProt PDB
Site Group ID: 41621432

In vivo Characterization
Methods used to characterize site in vivo:	mass spectrometry ( 1 )
Disease tissue studied:	non-small cell lung cancer ( 1 ) , non-small cell lung adenocarcinoma ( 1 )
Relevant cell line - cell type - tissue:	NCI-H2228 (pulmonary) ( 1 )

References
1	Rikova K (2013) CST Curation Set: 18449; Year: 2012; Biosample/Treatment: cell line, H2228/crizotinib, geldanamycin; Disease: -; TMT: Y; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pY Antibodies Used to Purify Peptides prior to LCMS: Phospho-Tyrosine (P-Tyr-1000) MultiMab(TM) Rabbit mAb mix Cat#: 8954 Curated Info

Developed with grants from

and literature mining with Linguamatics

PhosphoSite, created by Cell Signaling Technology is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported License.